04 Mar 2015
Increasing activity of glucagon-like peptide-1 (GLP-1) is associated with an increased incidence of intestinal tumours in mice, raising concerns about the use of drugs that elevate levels of GLP-1 in humans to treat diabetes and other metabolic diseases.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024